Improvements to tiny body-on-a-chip devices could lead to next-generation pre-clinical testing of drug toxicity
Researchers at Kyoto University’s Institute for Integrated Cell-Material Sciences (iCeMS) in Japan have designed a small ‘body-on-a-chip’ device that can test the side effects of drugs s on human cells. The device solves some issues with current, similar microfluidic devices and offers promise for the next generation of pre-clinical drug tests.
The Integrated Heart/Cancer on a Chip (iHCC) was used to test the toxicity of the anti-cancer drug doxorubicin on heart cells. The researchers, led by iCeMS’s Ken-ichiro Kamei, found that, while the drug itself was not toxic to heart cells, a metabolite of the drug resulting from its interaction with cancer cells was.
The device is smaller than a microscope glass slide. It contains six tiny chambers; every two are connected by microchannels with a series of port inlets and valves. A pneumatic pump controls movement of fluid through the channels. Every two chambers and their separate microchannel system constitute one test bed. Three test beds in the device allow for the introduction of minor changes in each bed to simultaneously compare results.
The team first tested doxorubicin’s effects on heart cells and liver cancer cells cultured separately in small wells. The drug had the expected anti-cancer effect on the cancer cells without causing damage to the heart cells.
They then ran the test using the iHCC device. Heart cells were placed in one chamber while liver cancer cells were placed in the other. Doxorubicin was introduced into a cell culture medium circulating through a closed-loop system of microchannels that connects the two chambers, mimicking the blood’s circulatory system. In this way, the drug flows unidirectionally in a continuous loop through both chambers.
The team found signs of toxicity in both cancer and heart cells. They hypothesized that a compound, doxorubicinol, which is a metabolic byproduct of doxorubicin interacting with cancer cells, was causing the toxic effect.
To test this, they added doxorubicinol to heart cells and liver cancer cells cultured separately in small wells. It was toxic to the heart cells but not to the cancer cells.
When doxorubicin alone is added to the liver cancer cells, the amount of doxorubicinol produced is too small to be toxic to the heart cells. The team believes this is because the amount of cell culture medium needed for the well-based tests dilutes the metabolite.
In contrast, when doxorubicin is introduced into the iHCC, the metabolite is not diluted when moving through the microchannel circulation system because a smaller volume of cell culture is needed. As a result, the drug does have a toxic effect on the heart cells via its metabolite.
The device requires further improvements, but the study demonstrates how this design concept could be used to investigate the toxic side effects of anti-cancer drugs on heart cells well before expensive clinical trials. The study was published in the journal Royal Society of Chemistry Advances.
Learn more: Next-generation drug testing on chips
The Latest on: Body-on-a-chip
[google_news title=”” keyword=”body-on-a-chip” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
- Leftovers: Oreo goes sour | Campbell Soup’s Late July chip dips back into salsaon April 26, 2024 at 9:01 am
Mondelēz International leverages its Sour Patch Kids brand to create an unusual flavor combination and General Mills launches a “guilt-free” donut.
- ICEA bats for chip design, manufacturing to be treated as strategic sectoron April 25, 2024 at 10:45 am
Industry body ICEA has recommended various measures, including encouraging large Indian corporates to invest in semiconductor design and treating chip design and manufacturing as a strategic sector, ...
- Treat semiconductor chip manufacturing as a strategic sector: ICEAon April 25, 2024 at 3:20 am
ICEA, in its report, emphasised the critical need to develop a holistic design ecosystem encompassing the entire electronics value chain.
- ICEA shares blueprint for India to become a global leader in chip value chainon April 25, 2024 at 3:18 am
As India embarks on its ambitious semiconductor journey, providing strategic support for chip design firms, bridging the skill gap, enhancing funding mechanisms, leveraging global opportunities and ...
- Nvidia's Moat Remains Unchallenged Despite Emerging Players' Advanced AI Chipson April 24, 2024 at 8:05 pm
Upstart's focus on AI-specific chip efficiency might outperform Nvidia’s broader approach. Read why NVDA stock is a Buy despite challenges.
- Micron: CHIP Grants Are Rocket Fuel (Rating Upgrade)on April 24, 2024 at 9:41 am
Micron Technology's recent partnership with Nvidia is expected to drive sustained growth and profitability. Read why I am upgrading MU stock to a strong buy.
- Bioelectronic chip detects vitamins C and D in saliva in under 20 minuteson April 24, 2024 at 9:39 am
Researchers at the University of São Paulo (USP) in Brazil have developed a bioelectronic chip that simultaneously detects vitamins C and D in body fluids. It is flexible and easy to see and can be ...
- Eddie Redmayne Lives a ‘Monastic’ Life for Broadway’s ‘Cabaret’: Lay’s Chips for Lozenges and ‘the Most Painful Massage’on April 24, 2024 at 6:29 am
Eddie Redmayne details his 'monastic' life behind the scenes of Broadway's 'Cabaret at the Kit Kat Club,' in which he stars as the Emcee.
- Prince George is ‘a chip off the old block’ says body language expert as she highlights the similarities between him and his dad Prince Williamon April 22, 2024 at 5:12 pm
A body language expert has highlighted the many sweet similarities between Prince William and his son Prince George, saying the youngster is ‘like a chip off the old block.’ ...
- Quest Nutrition Peanut Butter Chocolate Chip High Protein Cookie, Now 19% Offon April 22, 2024 at 11:34 am
Amazon is home to a plethora of choices when it comes to protein cookies, but the Quest Nutrition Peanut Butter Chocolate Chip High Protein Cookie stand out for several significant reasons. Currently ...
via Google News and Bing News